Indeed, our results indicated there was a clear benefit as evidenced by a decrease in mortality rate and amelioration of pulmonary fibrosis in bleomycin/MHV68-treated AECII CYB5R3-KO mice that were fed sGC agonist diets. The gene discussed is SGCB; the disease is pulmonary fibrosis.